Home » CGT CDMO » Lentiviral Vector CDMO Services » LVV Manufacturing

ProBio LVV Manufacturing

ProBio is experienced in manufacturing lentiviral vectors adopting both adherent system and suspension system. We use licensed PowerATM-293T cell lines, and developed our proprietary suspension cell line PowerSTM-293T, with the production capacity from 2L to 200L.

Our experts will discuss your project with you in detail and propose a best solution to accelerate your project.

IND
Phase I
Phase II
Phase III
BLA
Pre-Clinical
Commercial
Clinical GMP Grade
GMP Grade
BLA PC/PV
GMP Grade

Suspension Culture System

  • Proprietary cell line PowerSTM-293T
  • Stable and scalable suspension manufacturing process
  • up to 200L manufacturing scale
  • 4~5 times final yield improvement comparing with adherent culture system
  • ~50% cost reduction
  • High T cell transduction efficiency

PowerSTM-293T

  • Proprietary Suspension cell line
  • License for IND, clinical and commercial
  • Royalty free, maintenance free
  • Excellent performance in producing lentiviral vector

LVV Production: PowerSTM-293T with Different GOI

Titer over 107 TU/ml

Adherent Culture System

  • The largest manufacturing scales is Up to 96L
  • Closed culture system reduces contamination and improves stability
  • Full-automatic operation improves reproducibility and stability

Accumulated Experience

ProBio has accumulated rich experience in manufacturing lentiviral vector, which guaranteed a dedicated and professional service for customers.

  • Worked with global clients for their LVV projects
  • Provided GMP lentiviral vector for CAR-T, TCR-T projects
  • Over 100 GMP manufacturing batches experience

Related Services